Laboratory Corporation of Ameri – Consensus Indicates Potential 27.1% Upside
Laboratory Corporation of Ameri with ticker code (LH) now have 13 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 320 and 265 calculating the average target price we see 303.69. With the stocks previous close at 238.85 this is indicating there is a potential upside of 27.1%. The 50 day moving average now sits at 244.47 and the 200 moving average now moves to 264.93. The company has a market cap of $21,045m. You can visit the company''s website by visiting: https:||www.labcorp.com [stock_market_widget type="chart" template="basic" color="green" assets="LH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,758m based on the market concensus. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Laboratory Corporation of Ameri – Consensus Indicates Potential 27.1% Upside
Laboratory Corporation of Ameri with ticker code (LH) now have 13 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 320 and 265 calculating the average target price we see 303.69. With the stocks previous close at 238.85 this is indicating there is a potential upside of 27.1%. The 50 day moving average now sits at 244.47 and the 200 moving average now moves to 264.93. The company has a market cap of $21,045m. You can visit the company''s website by visiting: https:||www.labcorp.com [stock_market_widget type="chart" template="basic" color="green" assets="LH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,758m based on the market concensus. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.